Literature DB >> 28002079

Unbiased and targeted mass spectrometry for the HDL proteome.

Sasha A Singh1, Masanori Aikawa.   

Abstract

PURPOSE OF REVIEW: Mass spectrometry is an ever evolving technology that is equipped with a variety of tools for protein research. Some lipoprotein studies, especially those pertaining to HDL biology, have been exploiting the versatility of mass spectrometry to understand HDL function through its proteome. Despite the role of mass spectrometry in advancing research as a whole, however, the technology remains obscure to those without hands on experience, but still wishing to understand it. In this review, we walk the reader through the coevolution of common mass spectrometry workflows and HDL research, starting from the basic unbiased mass spectrometry methods used to profile the HDL proteome to the most recent targeted methods that have enabled an unprecedented view of HDL metabolism. RECENT
FINDINGS: Unbiased global proteomics have demonstrated that the HDL proteome is organized into subgroups across the HDL size fractions providing further evidence that HDL functional heterogeneity is in part governed by its varying protein constituents. Parallel reaction monitoring, a novel targeted mass spectrometry method, was used to monitor the metabolism of HDL apolipoproteins in humans and revealed that apolipoproteins contained within the same HDL size fraction exhibit diverse metabolic properties.
SUMMARY: Mass spectrometry provides a variety of tools and strategies to facilitate understanding, through its proteins, the complex biology of HDL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28002079      PMCID: PMC6211176          DOI: 10.1097/MOL.0000000000000374

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  66 in total

1.  Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers.

Authors:  Namita Pendharkar; Akshada Gajbhiye; Khushman Taunk; Sourav RoyChoudhury; Snigdha Dhali; Shubhendu Seal; Anupama Mane; Subodhini Abhang; Manas K Santra; Koel Chaudhury; Srikanth Rapole
Journal:  J Proteomics       Date:  2015-11-28       Impact factor: 4.044

2.  Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteins.

Authors:  Michael E Lassman; Thomas McAvoy; Anita Y H Lee; Derek Chappell; Oitak Wong; Haihong Zhou; Gissette Reyes-Soffer; Henry N Ginsberg; John S Millar; Daniel J Rader; David E Gutstein; Omar Laterza
Journal:  Clin Chem       Date:  2014-04-21       Impact factor: 8.327

3.  PP032. Apolipoprotein profiling in umbilical cord blood of intrauterine growth restricted (IUGR) neonates.

Authors:  Ulrich Pecks; Manja Wölter; Christoph Borchers; Derek Smith; Nicolai Maass; Michael Glocker; Werner Rath
Journal:  Pregnancy Hypertens       Date:  2013-06-06       Impact factor: 2.899

4.  Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring.

Authors:  Sasha A Singh; Allison B Andraski; Brett Pieper; Wilson Goh; Carlos O Mendivil; Frank M Sacks; Masanori Aikawa
Journal:  J Lipid Res       Date:  2016-02-09       Impact factor: 5.922

5.  A fast semi-quantitative LC-MS method for measurement of intact apolipoprotein A-I reveals novel proteoforms in serum.

Authors:  M Gåfvels; P Bengtson
Journal:  Clin Chim Acta       Date:  2015-01-17       Impact factor: 3.786

6.  FLEXIQuant: a novel tool for the absolute quantification of proteins, and the simultaneous identification and quantification of potentially modified peptides.

Authors:  Sasha Singh; Michael Springer; Judith Steen; Marc W Kirschner; Hanno Steen
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

7.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

8.  Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.

Authors:  Han-Byoel Lee; Un-Beom Kang; Hyeong-Gon Moon; Jiwoo Lee; Kyung-Min Lee; Minju Yi; Yong Sun Park; Jong Won Lee; Jong-Han Yu; Seung Ho Choi; Sang Heon Cho; Cheolju Lee; Wonshik Han; Dong-Young Noh
Journal:  Anticancer Res       Date:  2015-11       Impact factor: 2.480

9.  Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.

Authors:  Graziella E Ronsein; Nathalie Pamir; Priska D von Haller; Daniel S Kim; Michael N Oda; Gail P Jarvik; Tomas Vaisar; Jay W Heinecke
Journal:  J Proteomics       Date:  2014-10-31       Impact factor: 4.044

10.  Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.

Authors:  Xu Zhao; Yue Yu; Wenlong Xu; Lei Dong; Yuan Wang; Bing Gao; Guangyu Li; Wentao Zhang
Journal:  Int J Mol Sci       Date:  2016-03-28       Impact factor: 5.923

View more
  6 in total

1.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

Review 2.  Deepening our understanding of HDL proteome.

Authors:  Graziella Eliza Ronsein; Tomáš Vaisar
Journal:  Expert Rev Proteomics       Date:  2019-08-27       Impact factor: 3.940

3.  Serum and Lipoprotein Particle miRNA Profile in Uremia Patients.

Authors:  Markus Axmann; Sabine M Meier; Andreas Karner; Witta Strobl; Herbert Stangl; Birgit Plochberger
Journal:  Genes (Basel)       Date:  2018-11-05       Impact factor: 4.096

4.  Metabolism of PLTP, CETP, and LCAT on multiple HDL sizes using the Orbitrap Fusion Lumos.

Authors:  Sasha A Singh; Allison B Andraski; Hideyuki Higashi; Lang Ho Lee; Ashisha Ramsaroop; Frank M Sacks; Masanori Aikawa
Journal:  JCI Insight       Date:  2021-02-08

Review 5.  Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines.

Authors:  Emanuele Papini; Regina Tavano; Fabrizio Mancin
Journal:  Front Immunol       Date:  2020-10-12       Impact factor: 7.561

6.  Lipoprotein proteome profile: novel insight into hyperlipidemia.

Authors:  Miao Lin; Menglin Li; Hao Zheng; Haidan Sun; Jinlan Zhang
Journal:  Clin Transl Med       Date:  2021-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.